Menu ×

HEALTHCARE & PHARMACEUTICAL

Typhus Fever Treatment Market Segmentation by Type (Murine Typhus, Epidemic, and Scrub Typhus); by Treatment (Antibiotic Therapy, and Others); by Medication (Doxycycline, Ciprofloxacin, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More

IN THE NEWS

  • September, 2021: ViiV Healthcare, collectively owned by GlaxoSmithKline plc, Pfizer Inc. and Shionogi announced approval of the U.S. Food and Drug Administration (FDA) for cabotegravir as an antiviral drug.
  • June, 2020: GlaxoSmithKline plc and Vir Biotechnology, Inc. to conduct the Phase 3 trial of sotrovimab antimicrobial drug.

Global Typhus Fever Treatment Market Highlights over 2022 – 2030

The global typhus fever treatment market is estimated to grow at a moderate CAGR over the forecast period, i.e., 2022 – 2030. Typhus fever is caused by a bacteria found in mites, and bugs. When a mite carrying the bacteria bites someone, the bacteria can cause infection by entering the bloodstream. The growth of the market can be attributed to the increasing incidences of typhus fever across the globe, especially in low- and middle-income countries. The lack of sanitation facilities, personal hygiene, and housing overcrowding are the major causes for infection of typhus fever. The population of the world is increasing at a concerning rate, and housing this growing population is a major problem. According to the data by the World Bank, the global population reached 7.753 billion in 2020, which was 6.922 billion just a decade ago.

Typhus Fever Treatment Market

Get more information on this reportDownload Sample PDF

The lack of sanitation is another major factor responsible of the outbreaks of typhus fever, especially in under-developed countries. According to the data by the World Health Organization (WHO), 2 billion people globally do not have access to basic sanitation facilities, such as, toilets, and 673 million people still defecate in open. Moreover, housing overcrowding or people living in overcrowded conditions, is another major factor estimated to boost the market growth. As per the data by Organization for Economic Co-operation and Development (OECD), a household is considered as overcrowded if less than one room is available in each household for every couple, individual above 18 years, and a pair of children below 18 years. Mexico is one of the most overcrowded countries in the world, with 33.191% of the population living in overcrowded households. 

Global Population

The market is segmented by type into murine typhus, epidemic, and scrub typhus, out of which, the scrub typhus segment is anticipated to hold the largest share in the global typhus fever treatment market over the forecast period on account of highest prevalence of this type of typhus across the world. Scrub typhus spreads faster than the other two type, which is estimated to boost the segment growth.

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Typhus Fever Treatment Market Regional Synopsis

On the basis of geographical analysis, the global typhus fever treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Latin America region is estimated to witness noteworthy growth over the forecast period on the back of lack of sanitation facilities, and overcrowding housing in low-income countries. The market in the Asia Pacific region is also projected to grow similarly over the forecast period, owing to the poor housing conditions, over-population, and lack of healthcare awareness. According to the statistics by the World Health Organization (WHO), around 827,000 people in low- and middle-income countries die due to inadequate sanitation.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the increasing prevalence of typhus fever in the region, backed by growing cases of mite and bug infestation.

Typhus Fever Treatment Market

Get more information on this reportDownload Sample PDF

The global typhus fever treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global typhus fever treatment market includes the following segments:

By Type

  • Murine Typhus
  • Epidemic
  • Scrub Typhus

By Treatment

  • Antibiotic Therapy
  • Others

By Medication

  • Doxycycline
  • Ciprofloxacin
  • Others

Growth Drivers

  • Growing Prevalence of Typhus Fever
  • Lack of Sanitation and Hygiene
  • Increasing Population and Overcrowding Housing

Challenges

  • Lack of Awareness regarding Healthcare
  • Circulation of Generic Drugs

Top Featured Companies Dominating the Market

  • Biogen, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Pfizer Inc.
  • Glenmark Pharmaceuticals
  • Merck KGaA
  • Novartis AG
  • Sanofi-aventis Groupe
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
  • Daiichi Sankyo Company, Limited
  • Siemens Healthcare GmbH

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved